ADMA Biologics, Inc. (ADMA) Q3 2023 Earnings Call Transcript

ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET

Company Participants

Skyler Bloom – Head, Business Development & Corporate Strategy

Adam Grossman – President & CEO

Brian Lenz – EVP, CFO & GM, ADMA BioCenters

Conference Call Participants

Kristen Kluska – Cantor Fitzgerald

Anthony Petrone – Mizuho Group

Gary Nachman – Raymond James


Good afternoon, and welcome to the ADMA Biologics Third Quarter 2023 Financial Results and Corporate Update Conference Call on Wednesday, November 8, 2023. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request and will be available on the company’s website approximately two hours following the end of the call.

At this time, I would like to introduce Skyler Bloom, Head of Business Development and Corporate Strategy at ADMA Biologics. Please go ahead.

Skyler Bloom

Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics financial results for the third quarter of 2023 and recent corporate updates. I am joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President, Chief Financial Officer and General Manager of ADMA BioCenters.

During today’s call, Adam will provide some introductory comments and provide an update on corporate progress, and then Brian will provide an overview of the company’s third quarter 2023 financial results. Finally, Adam will then provide some brief summary remarks before opening up the call for your questions.

Earlier today, we issued a press release detailing the third quarter 2023 financial results and summarize certain achievements in recent corporate updates. The release is available on our website at

Before we begin our formal comments, I’ll remind you that we will be

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *